Modus Therapeutics Holding AB (MODTX) — Defensive Interval Ratio
Modus Therapeutics Holding AB (MODTX) has a Defensive Interval Ratio of 133 days as of December 2025. Defensive assets of Skr1.31 Million (cash Skr-, short-term investments Skr-, receivables Skr1.31 Million) cover 133 days of daily cash needs of Skr9.90K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Modus Therapeutics Holding AB Defensive Interval Ratio (2018–2025)
This chart shows how Modus Therapeutics Holding AB's Defensive Interval Ratio has evolved across 8 annual periods from 2018 to 2025. As of December 2025, the ratio stands at 133 days, meaning defensive assets of Skr1.31 Million can fund 133 days of operations without new revenue. For the complete balance sheet picture, see Modus Therapeutics Holding AB balance sheet assets.
Annual Defensive Interval Ratio for Modus Therapeutics Holding AB (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for Modus Therapeutics Holding AB from 2018 to 2025, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital to net assets of Modus Therapeutics Holding AB to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (SEK) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 133 days | Skr1.31 Million | Skr9.90K/day | Skr- | Skr- | ▲ +107 days |
| 2024 | 25 days | Skr189.00K | Skr7.53K/day | Skr- | Skr- | ▼ -30 days |
| 2023 | 55 days | Skr357.00K | Skr6.46K/day | Skr- | Skr- | ▲ +49 days |
| 2022 | 6 days | Skr230.00K | Skr37.96K/day | Skr- | Skr- | ▼ -11 days |
| 2021 | 17 days | Skr249.00K | Skr14.95K/day | Skr- | Skr- | ▼ -91 days |
| 2020 | 107 days | Skr146.00K | Skr1.36K/day | Skr- | Skr- | ▲ +55 days |
| 2019 | 52 days | Skr675.00K | Skr12.98K/day | Skr- | Skr- | ▲ +34 days |
| 2018 | 18 days | Skr1.11 Million | Skr63.15K/day | Skr- | Skr- | — |